Biocompatibility and safety of a hybrid core–shell nanoparticulate OP-1 delivery system intramuscularly administered in rats
- 30 April 2010
- journal article
- research article
- Published by Elsevier BV in Biomaterials
- Vol. 31 (10), 2746-2754
- https://doi.org/10.1016/j.biomaterials.2009.12.034
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Synthetic Alginate is a Carrier of OP-1 for Bone InductionClinical Orthopaedics and Related Research, 2009
- Metabolic Profiles of Serum from Rats after Subchronic Exposure to Chlorpyrifos and CarbarylChemical Research in Toxicology, 2009
- Protein release kinetics for core–shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomesBiomaterials, 2008
- Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery)Journal of Tissue Engineering and Regenerative Medicine, 2008
- Respiratory Tract Lesions in Noninhalation StudiesToxicologic Pathology, 2007
- Early injection of OP-1 during distraction osteogenesis accelerates new bone formation in rabbitsGrowth Factors, 2006
- Toxicity and Tissue Distribution of Magnetic Nanoparticles in MiceToxicological Sciences, 2005
- Osteoinduction by Recombinant Human Bone Morphogenetic Protein-2 in Muscles of Non-Human PrimatesJournal of International Medical Research, 2002
- Biodegradable Long-Circulating Polymeric NanospheresScience, 1994
- Drug deliveryCurrent Opinion in Biotechnology, 1991